Orexigen Therapeutics Inc (OTC Pink - No Information:OREXQ)

0.137
Delayed Data
As of May 18
 +0.002 / +1.48%
Today’s Change
0.09
Today|||52-Week Range
3.28
-89.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues3.4M55.5M24.5M33.7M
 
 
 
 
 
Cost of Goods Sold0.00----7.6M
 
 
Depreciation And Amortization94.0K139.0K223.0K3.7M
 
 
 
 
 
 
Operating ExpensesGross Income3.3M----22.4M
 
 
 
General Expenses80.5M85.9M84.3M156.6M
 
 
 
 
 
Research And Development56.7M57.4M40.8M38.0M
 
 
 
 
 
Total Operating Expenses80.6M86.1M84.5M167.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-77.2M-30.5M-60.1M-134.2M
 
 
 
 
 
Extraordinary Credit0.00--0.00123.9M
 
 
Extraordinary Charge0.00--0.00-3.0M
 
 
Interest Expense On Debt538.0K7.1M7.4M7.9M
 
 
 
 
 
Other Expenses0.000.00-39.0K-3.9M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-77.7M-37.5M-67.3M-24.4M
 
 
 
 
 
Income Taxes0.000.00-1.4M-133.0K
 
 
 
Net Income-77.7M-37.5M-68.7M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.6M11.8M13.1M14.6M
 
 
 
 
 
Shares To Calculate EPS Diluted9.6M11.8M13.1M14.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.00-$3.20-$5.20-$1.68
 
 
 
 
 
EPS Diluted-$8.00-$3.20-$5.20-$1.68